{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:20:59Z","timestamp":1794068459281,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T00:00:00Z","timestamp":1548374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12951-019-0451-9","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T08:02:42Z","timestamp":1548403362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":225,"title":["Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats"],"prefix":"10.1186","volume":"17","author":[{"given":"Chang-xiong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-zhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-bing","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"451_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","volume":"13","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13:193.","journal-title":"Nat Rev Cardiol."},{"key":"451_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jacc.2011.07.054","volume":"59","author":"PZ Gerczuk","year":"2012","unstructured":"Gerczuk PZ, Kloner RA. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol. 2012;59:969.","journal-title":"J Am Coll Cardiol"},{"key":"451_CR3","first-page":"935","volume":"38","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B, et al. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J. 2017;38:935.","journal-title":"Eur Heart J"},{"key":"451_CR4","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung TT, Morel O, Cayla G, Rioufol G, Garciadorado D, Angoulvant D, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J med. 2015;373:1021.","journal-title":"N Engl J med"},{"key":"451_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-73344-9_20","volume-title":"Pharmacological targeting of the mitochondrial permeability transition pore for cardioprotection","author":"FSG Silva","year":"2018","unstructured":"Silva FSG, Costa CF, Marques RJ, Oliveira PJ, Pereira GC. Pharmacological targeting of the mitochondrial permeability transition pore for cardioprotection. Berlin: Springer; 2018."},{"key":"451_CR6","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nature03317","volume":"434","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature. 2005;434:652.","journal-title":"Nature"},{"key":"451_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 2005;434:658.","journal-title":"Nature"},{"key":"451_CR8","first-page":"357","volume":"255","author":"M Crompton","year":"1988","unstructured":"Crompton M, Ellinger H, Costi A. Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J. 1988;255:357.","journal-title":"Biochem J."},{"key":"451_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1042\/bj2680153","volume":"268","author":"AP Halestrap","year":"1990","unstructured":"Halestrap AP, Davidson AM. Inhibition of Ca2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J. 1990;268:153.","journal-title":"Biochem J."},{"issue":"Pt 2","key":"451_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1042\/bj2740611","volume":"274","author":"EJ Griffiths","year":"1991","unstructured":"Griffiths EJ, Halestrap AP. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. Biochem J. 1991;274(Pt 2):611.","journal-title":"Biochem J."},{"key":"451_CR11","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1007\/s00018-017-2502-4","volume":"74","author":"S Javadov","year":"2017","unstructured":"Javadov S, Jang S, Parodi-Rullan R, Khuchua Z, Kuznetsov AV. Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection? Cell Mol Life Sci. 2017;74:2795.","journal-title":"Cell Mol Life Sci"},{"key":"451_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000446850","volume":"42","author":"N Nighoghossian","year":"2016","unstructured":"Nighoghossian N, Ovize M, Mewton N, Ong E, Cho TH. Cyclosporine A, a potential therapy of ischemic reperfusion injury. A common history for heart and brain. Cerebrovasc Dis. 2016;42:309.","journal-title":"Cerebrovasc Dis."},{"key":"451_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fphar.2018.00238","volume":"9","author":"FA Rahman","year":"2018","unstructured":"Rahman FA, Abdullah SS, Manan W, Tan LT, Neoh CF, Ming LC, et al. Efficacy and safety of cyclosporine in acute myocardial infarction: a systematic review and meta-analysis. Front Pharmacol. 2018;9:238.","journal-title":"Front Pharmacol."},{"key":"451_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJMoa071142","volume":"359","author":"C Piot","year":"2008","unstructured":"Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med. 2008;359:473.","journal-title":"N Engl J Med"},{"key":"451_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/ALN.0000000000000331","volume":"121","author":"P Chiari","year":"2014","unstructured":"Chiari P, Angoulvant D, Mewton N, Desebbe O, Obadia JF, Robin J, et al. Cyclosporine protects the heart during aortic valve surgery. Anesthesiology. 2014;121:232.","journal-title":"Anesthesiology"},{"key":"451_CR16","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1161\/01.CIR.90.5.2439","volume":"90","author":"LD Horwitz","year":"1994","unstructured":"Horwitz LD, Kaufman D, Keller MW, Kong Y. Time course of coronary endothelial healing after injury due to ischemia and reperfusion. Circulation. 1994;90:2439.","journal-title":"Circulation"},{"key":"451_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ejhf.463","volume":"18","author":"GU Ruiz-Esparza","year":"2016","unstructured":"Ruiz-Esparza GU, Segura-Ibarra V, Cordero-Reyes AM, Youker KA, Serda RE, Cruz-Solbes AS, et al. A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics. Eur J Heart Fail. 2016;18:169.","journal-title":"Eur J Heart Fail"},{"key":"451_CR18","doi-asserted-by":"publisher","first-page":"1701276","DOI":"10.1002\/smll.201701276","volume":"13","author":"MPA Ferreira","year":"2017","unstructured":"Ferreira MPA, Ranjan S, Kinnunen S, Correia A, Talman V, Makila E, et al. Drug-loaded multifunctional nanoparticles targeted to the endocardial layer of the injured heart modulate hypertrophic signaling. Small. 2017;13:1701276.","journal-title":"Small."},{"key":"451_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biomaterials.2016.03.046","volume":"94","author":"MP Ferreira","year":"2016","unstructured":"Ferreira MP, Ranjan S, Correia AM, Makila EM, Kinnunen SM, Zhang H, et al. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles. Biomaterials. 2016;94:93.","journal-title":"Biomaterials"},{"key":"451_CR20","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1021\/nl2025882","volume":"11","author":"T Dvir","year":"2011","unstructured":"Dvir T, Bauer M, Schroeder A, Tsui JH, Anderson DG, Langer R, et al. Nanoparticles targeting the infarcted heart. Nano Lett. 2011;11:4411.","journal-title":"Nano Lett"},{"key":"451_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.RES.0000173376.39447.01","volume":"97","author":"ME Davis","year":"2005","unstructured":"Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT. Custom design of the cardiac microenvironment with biomaterials. Circ Res. 2005;97:8.","journal-title":"Circ Res"},{"key":"451_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drudis.2014.09.018","volume":"20","author":"D Pandita","year":"2015","unstructured":"Pandita D, Kumar S, Lather V. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives. Drug Discov Today. 2015;20:95.","journal-title":"Drug Discov Today."},{"key":"451_CR23","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1007\/s11095-015-1748-5","volume":"32","author":"M Riffault","year":"2015","unstructured":"Riffault M, Six JL, Netter P, Gillet P, Grossin L. PLGA-based nanoparticles: a safe and suitable delivery platform for osteoarticular pathologies. Pharm Res. 2015;32:3886.","journal-title":"Pharm Res"},{"key":"451_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28.","journal-title":"Adv Drug Deliv Rev"},{"key":"451_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"DE Owens III","year":"2006","unstructured":"Owens DE III, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93.","journal-title":"Int J Pharm"},{"key":"451_CR26","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/bph.12461","volume":"171","author":"HH Szeto","year":"2014","unstructured":"Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171:2029.","journal-title":"Br J Pharmacol"},{"key":"451_CR27","first-page":"e50166","volume":"73","author":"BC Evans","year":"2013","unstructured":"Evans BC, Nelson CE, Yu SS, Beavers KR, Kim AJ, Li H, et al. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J Vis Exp. 2013;73:e50166.","journal-title":"J Vis Exp."},{"key":"451_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijbiomac.2014.08.035","volume":"72","author":"JK Yan","year":"2015","unstructured":"Yan JK, Ma HL, Chen X, Pei JJ, Wang ZB, Wu JY. Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin. Int J Biol Macromol. 2015;72:333.","journal-title":"Int J Biol Macromol"},{"key":"451_CR29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jbm.a.33148","volume":"98","author":"FK Andrade","year":"2011","unstructured":"Andrade FK, Silva JP, Carvalho M, Castanheira EM, Soares R, Gama M. Studies on the hemocompatibility of bacterial cellulose. J Biomed Mater Res A. 2011;98:554.","journal-title":"J Biomed Mater Res A."},{"key":"451_CR30","doi-asserted-by":"publisher","first-page":"e001644","DOI":"10.1161\/JAHA.112.001644","volume":"1","author":"RA Kloner","year":"2012","unstructured":"Kloner RA, Hale SL, Dai W, Gorman RC, Shuto T, Koomalsingh KJ, et al. Reduction of ischemia\/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide. J Am Heart Assoc. 2012;1:e001644.","journal-title":"J Am Heart Assoc."},{"key":"451_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2217\/nnm.12.125","volume":"8","author":"M Miragoli","year":"2013","unstructured":"Miragoli M, Novak P, Ruenraroengsak P, Shevchuk AI, Korchev YE, Lab MJ, et al. Functional interaction between charged nanoparticles and cardiac tissue: a new paradigm for cardiac arrhythmia? Nanomedicine. 2013;8:725.","journal-title":"Nanomedicine."},{"key":"451_CR32","doi-asserted-by":"publisher","first-page":"E277","DOI":"10.1007\/BF02854898","volume":"8","author":"HH Szeto","year":"2006","unstructured":"Szeto HH. Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J. 2006;8:E277.","journal-title":"AAPS J"},{"key":"451_CR33","first-page":"629","volume":"8","author":"GU Ruiz-Esparza","year":"2013","unstructured":"Ruiz-Esparza GU, Flores-Arredondo JH, Segura-Ibarra V, Torre-Amione G, Ferrari M, Blanco E, et al. The physiology of cardiovascular disease and innovative liposomal platforms for therapy. Int J Nanomed. 2013;8:629.","journal-title":"Int J Nanomed"},{"key":"451_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0008-6363(03)00344-4","volume":"59","author":"ZQ Zhao","year":"2003","unstructured":"Zhao ZQ, Morris CD, Budde JM, Wang NP, Muraki S, Sun HY, et al. Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res. 2003;59:132.","journal-title":"Cardiovasc Res"},{"key":"451_CR35","doi-asserted-by":"publisher","first-page":"23025","DOI":"10.1038\/srep23025","volume":"6","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Xu L, Qiao Z, Gao L, Ding S, Ying X, et al. YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia\/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor alpha. Sci Rep. 2016;6:23025.","journal-title":"Sci Rep."},{"key":"451_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/0076-6879(95)60154-6","volume":"260","author":"M Reers","year":"1995","unstructured":"Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 1995;260:406.","journal-title":"Methods Enzymol"},{"key":"451_CR37","doi-asserted-by":"publisher","first-page":"H1125","DOI":"10.1152\/ajpheart.00436.2008","volume":"296","author":"M Saotome","year":"2009","unstructured":"Saotome M, Katoh H, Yaguchi Y, Tanaka T, Urushida T, Satoh H, et al. Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2009;296:H1125.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"451_CR38","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1471-2407-14-271","volume":"14","author":"X Ding","year":"2014","unstructured":"Ding X, Zhang B, Pei Q, Pan J, Huang S, Yang Y, et al. Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1. BMC Cancer. 2014;14:271.","journal-title":"BMC Cancer."},{"key":"451_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","volume":"105","author":"JW Calvert","year":"2009","unstructured":"Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res. 2009;105:365.","journal-title":"Circ Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-019-0451-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12951-019-0451-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-019-0451-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T00:08:18Z","timestamp":1579910898000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-019-0451-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1186\/s12951-019-0451-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,25]]},"assertion":[{"value":"9 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}